Alpha Teknova, Inc. (TKNO)
USD 5.55
(2.5%)
USD 5.55
(2.5%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 45.85 Million USD | -14.43% |
| 2022 | 46.33 Million USD | 56.38% |
| 2021 | 29.62 Million USD | 126.31% |
| 2020 | 13.09 Million USD | 25.52% |
| 2019 | 10.43 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 8.6 Million USD | -11.59% |
| 2024 Q2 | 7.61 Million USD | -11.51% |
| 2023 Q2 | 9.86 Million USD | -13.2% |
| 2023 Q1 | 11.36 Million USD | -6.49% |
| 2023 FY | 39.64 Million USD | -14.43% |
| 2023 Q4 | 9.73 Million USD | -2.12% |
| 2023 Q3 | 9.94 Million USD | 0.8% |
| 2022 Q2 | 11.87 Million USD | 6.08% |
| 2022 FY | 46.33 Million USD | 56.38% |
| 2022 Q1 | 11.19 Million USD | 14.84% |
| 2022 Q3 | 11.11 Million USD | -6.42% |
| 2022 Q4 | 12.15 Million USD | 9.42% |
| 2021 Q4 | 9.74 Million USD | 19.57% |
| 2021 Q1 | 5.85 Million USD | 22.6% |
| 2021 FY | 29.62 Million USD | 126.31% |
| 2021 Q2 | 5.88 Million USD | 0.46% |
| 2021 Q3 | 8.15 Million USD | 38.62% |
| 2020 Q1 | 2.61 Million USD | 0.0% |
| 2020 FY | 13.09 Million USD | 25.52% |
| 2020 Q4 | 4.77 Million USD | 62.6% |
| 2020 Q3 | 2.93 Million USD | 6.18% |
| 2020 Q2 | 2.76 Million USD | 5.66% |
| 2019 FY | 10.43 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Bright Green Corporation | 8.25 Million USD | -455.673% |
| ANI Pharmaceuticals, Inc. | 195.98 Million USD | 76.601% |
| Aquestive Therapeutics, Inc. | 44.85 Million USD | -2.241% |
| Collegium Pharmaceutical, Inc. | 159.2 Million USD | 71.196% |
| Cosmos Health Inc. | 26.18 Million USD | -75.163% |
| Journey Medical Corporation | 54.59 Million USD | 16.0% |
| Embecta Corp. | 528.4 Million USD | 91.321% |
| Esperion Therapeutics, Inc. | 271.89 Million USD | 83.134% |
| Dynavax Technologies Corporation | 219.14 Million USD | 79.074% |
| Intra-Cellular Therapies, Inc. | 590 Million USD | 92.227% |
| Pacira BioSciences, Inc. | 326.37 Million USD | 85.949% |
| PainReform Ltd. | 9.58 Million USD | -378.495% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | -249.416% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | -249.416% |
| SCYNEXIS, Inc. | 51.84 Million USD | 11.551% |
| Safety Shot Inc | 12.1 Million USD | -278.697% |
| China SXT Pharmaceuticals, Inc. | 3.06 Million USD | -1394.174% |
| Procaps Group, S.A. | 199.47 Million USD | 77.01% |
| Theratechnologies Inc. | 72.75 Million USD | 36.969% |
| Harrow Health, Inc. | 89.97 Million USD | 49.03% |
| Sonoma Pharmaceuticals, Inc. | 9.44 Million USD | -385.486% |
| Biofrontera Inc. | 39.95 Million USD | -14.765% |
| DURECT Corporation | 43.71 Million USD | -4.904% |
| Supernus Pharmaceuticals, Inc. | 529.01 Million USD | 91.331% |
| Cronos Group Inc. | 96.7 Million USD | 52.58% |
| OptiNose, Inc. | 85.1 Million USD | 46.113% |
| Ironwood Pharmaceuticals, Inc. | 232.12 Million USD | 80.244% |
| Kala Pharmaceuticals, Inc. | 39.15 Million USD | -17.128% |
| RedHill Biopharma Ltd. | -9.56 Million USD | 579.646% |
| Organogenesis Holdings Inc. | 314.13 Million USD | 85.401% |
| Guardion Health Sciences, Inc. | 9.73 Million USD | -371.275% |
| Cumberland Pharmaceuticals Inc. | 43.04 Million USD | -6.548% |
| Radius Health, Inc. | 265.92 Million USD | 82.755% |
| Universe Pharmaceuticals INC | 13.84 Million USD | -231.305% |
| ProPhase Labs, Inc. | 37.85 Million USD | -21.153% |
| Phibro Animal Health Corporation | 260.29 Million USD | 82.382% |
| Procaps Group S.A. | 187.24 Million USD | 75.509% |
| Alvotech | 285.43 Million USD | 83.934% |
| TherapeuticsMD, Inc. | 9.82 Million USD | -366.758% |
| Viatris Inc. | 5.96 Billion USD | 99.231% |
| Rockwell Medical, Inc. | 15.37 Million USD | -198.289% |
| Aytu BioPharma, Inc. | 59.84 Million USD | 23.364% |
| SIGA Technologies, Inc. | 22.04 Million USD | -108.043% |
| Tilray Brands, Inc. | 251.35 Million USD | 81.755% |
| Lifecore Biomedical, Inc. | 49.03 Million USD | 6.483% |
| Shineco, Inc. | 17.94 Million USD | -155.51% |
| PetIQ, Inc. | 192.72 Million USD | 76.205% |
| Regencell Bioscience Holdings Limited | 3.99 Million USD | -1049.021% |
| Incannex Healthcare Limited | 30.05 Million USD | -52.594% |
| Neurocrine Biosciences, Inc. | 1.59 Billion USD | 97.128% |
| Alimera Sciences, Inc. | 62.64 Million USD | 26.791% |
| Silver Spike Investment Corp. | 762.49 Thousand USD | -5914.358% |
| Assertio Holdings, Inc. | 368.58 Million USD | 87.558% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.88 Million USD | -679.177% |
| Petros Pharmaceuticals, Inc. | 17.8 Million USD | -157.511% |
| Clever Leaves Holdings Inc. | 21.16 Million USD | -116.633% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | -117.939% |
| Avadel Pharmaceuticals plc | 164.96 Million USD | 72.201% |
| Hempacco Co., Inc. | 7.59 Million USD | -503.69% |
| Talphera, Inc. | 11.99 Million USD | -282.35% |
| Alvotech | 285.43 Million USD | 83.934% |
| Eagle Pharmaceuticals, Inc. | 140.71 Million USD | 67.41% |
| Lantheus Holdings, Inc. | 344.9 Million USD | 86.704% |
| Currenc Group, Inc. | 24 Million USD | -91.063% |
| Kamada Ltd. | 45.42 Million USD | -0.953% |
| Indivior PLC | 911 Million USD | 94.966% |
| Evoke Pharma, Inc. | 12.4 Million USD | -269.543% |
| Flora Growth Corp. | 10.57 Million USD | -333.491% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | -117.939% |
| Evolus, Inc. | 189.75 Million USD | 75.833% |
| HUTCHMED (China) Limited | 436.23 Million USD | 89.487% |
| Amphastar Pharmaceuticals, Inc. | 154.13 Million USD | 70.247% |
| Akanda Corp. | 3.48 Million USD | -1216.46% |